Old Web
English
Sign In
Acemap
>
authorDetail
>
H. Zander
H. Zander
Paul Ehrlich Institute
Internal medicine
Oncology
European union
Medicine
Biomarker (medicine)
2
Papers
6
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The EMA assessment of pembrolizumab as monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer.
2021
A Trullas
Julio Delgado
A. Genazzani
J. Mueller-Berghaus
C. Migali
S. Müller-Egert
H. Zander
Harald Enzmann
Francesco Pignatti
Show All
Source
Cite
Save
Citations (5)
The European Medicines Agency review of the initial application of atezolizumab and the role of PD-L1 expression as biomarker for checkpoint inhibitors.
2021
I. Araujo-Fernandez
Julio Delgado
L. Moscetti
Sinan B. Sarac
H. Zander
S. Mueller-Egert
K. Dunder
Elias Péan
L. Bergmann
Harald Enzmann
Francesco Pignatti
Show All
Source
Cite
Save
Citations (1)
1